230-RICR-20-45-11
230-RICR-20-45-11. Corporate Governance (version Technical Revision, 01/01/2017 to 01/01/2017)
230-RICR-200-45-11
TITLE 230 – DEPARTMENT OF BUSINESS REGULATION
CHAPTER 200 - INSURANCE
SUBCHAPTER 45 – FINANCIAL STANDARDS AND CORPORATE OPERATIONS
PART 11 – CORPORATE GOVERNANCE
1.1
Authority
This regulation is promulgated pursuant to the authority granted R.I. Gen. Laws §
27-1.2-4.
1.2
Purpose
The purpose of this regulation is to set forth the procedures for filing and the
required contents of the Corporate Governance Annual Disclosure (CGAD),
deemed necessary by the Department to carry out the provisions of R.I. Gen.
Laws § 27-1.2.
1.3 Definitions
A.
For the purpose of this Regulation the following definitions shall apply:
1.
“Department” shall mean the Department of Business Regulation,
Insurance Division.
2.
“Insurance group.” For the purpose of this Act, the term “insurance group”
shall mean those insurers and affiliates included within an insurance
holding company system as defined in R.I. Gen. Laws §§ 27-35.
3.
“Insurer.” The term “insurer” shall have the same meaning as set forth in
R.I. Gen. Laws §§ 27-54.1-1(5), except that it shall not include agencies,
authorities or instrumentalities of the United States, its possessions and
territories, the Commonwealth of Puerto Rico, the District of Columbia, or
a state or political subdivision of a state.
4.
“Senior Management.” The term “senior management” shall mean any
corporate officer responsible for reporting information to the board of
directors at regular intervals or providing this information to shareholders
or regulators and shall include, for example and without limitation, the
Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), Chief
Operations Officer (“COO”), Chief Procurement Officer (“CPO”), Chief
Legal Officer (“CLO”), Chief Information Officer (“CIO”), Chief Technology
Officer (“CTO”), Chief Revenue Officer (“CRO”), Chief Visionary Officer
(“CVO”), or any other “C” level executive.
1.4
Filing Procedures
A.
An insurer, or the insurance group of which the insurer is a member, required to
file a CGAD by the R.I. Gen Laws § 27-1.2-3, shall, no later than June 1 of each
calendar year, submit to the Commissioner a CGAD that contains the information
described in Section 5 of these regulations.
B.
The CGAD must include a signature of the insurer’s or insurance group’s chief
executive officer or corporate secretary attesting to the best of that individual’s
belief and knowledge that the insurer or insurance group has implemented the
corporate governance practices and that a copy of the CGAD has been provided
to the insurer’s or insurance group’s Board of Directors (hereafter “Board”) or the
appropriate committee thereof.
C.
The insurer or insurance group shall have discretion regarding the appropriate
format for providing the information required by these regulations and is
permitted to customize the CGAD to provide the most relevant information
necessary to permit the Commissioner to gain an understanding of the corporate
governance structure, policies and practices utilized by the insurer or insurance
group.
D.
For purposes of completing the CGAD, the insurer or insurance group may
choose to provide information on governance activities that occur at the ultimate
controlling parent level, an intermediate holding company level and/or the
individual legal entity level, depending upon how the insurer or insurance group
has structured its system of corporate governance. The insurer or insurance
group is encouraged to make the CGAD disclosures at the level at which the
insurer’s or insurance group’s risk appetite is determined, or at which the
earnings, capital, liquidity, operations, and reputation of the insurer are overseen
collectively and at which the supervision of those factors are coordinated and
exercised, or the level at which legal liability for failure of general corporate
governance duties would be placed. If the insurer or insurance group determines
the level of reporting based on these criteria, it shall indicate which of the three
criteria was used to determine the level of reporting and explain any subsequent
changes in level of reporting.
E.
Notwithstanding Subsection A of this Section, and as outlined in Section 3 of the
Corporate Governance Annual Disclosure Model Act, if the CGAD is completed
at the insurance group level, then it must be filed with the lead state of the group
as determined by the procedures outlined in the most recent Financial Analysis
Handbook adopted by the NAIC. In these instances, a copy of the CGAD must
also be provided to the chief regulatory official of any state in which the insurance
group has a domestic insurer, upon request.
F.
An insurer or insurance group may comply with this section by referencing other
existing documents (e.g., ORSA Summary Report, Holding Company Form B or
F Filings, Securities and Exchange Commission (SEC) Proxy Statements, foreign
regulatory reporting requirements, etc.) if the documents provide information that
is comparable to the information described in Section 5. The insurer or insurance
group shall clearly reference the location of the relevant information within the
CGAD and attach the referenced document if it is not already filed or available to
the regulator.
G.
Each year following the initial filing of the CGAD, the insurer or insurance group
shall file an amended version of the previously filed CGAD indicating where
changes have been made. If no changes were made in the information or
activities reported by the insurer or insurance group, the filing should so state.
1.5
Contents of Corporate Governance Annual Disclosure
A.
The insurer or insurance group shall be as descriptive as possible in completing
the CGAD, with inclusion of attachments or example documents that are used in
the governance process, since these may provide a means to demonstrate the
strengths of their governance framework and practices.
B.
The CGAD shall describe the insurers or insurance group’s corporate
governance framework and structure including consideration of the following.
1.
The Board and various committees thereof ultimately responsible for
overseeing the insurer or insurance group and the level(s) at which that
oversight occurs (e.g., ultimate control level, intermediate holding
company, legal entity, etc.). The insurer or insurance group shall describe
and discuss the rationale for the current Board size and structure; and
2.
The duties of the Board and each of its significant committees and how
they are governed (e.g., bylaws, charters, informal mandates, etc.), as
well as how the Board’s leadership is structured, including a discussion of
the roles of Chief Executive Officer (CEO) and Chairman of the Board
within the organization.
C.
The insurer or insurance group shall describe the policies and practices of the
most senior governing entity and significant committees thereof, including a
discussion of the following factors:
1.
How the qualifications, expertise and experience of each Board member
meet the needs of the insurer or insurance group.
2.
How an appropriate amount of independence is maintained on the Board
and its significant committees.
3.
The number of meetings held by the Board and its significant committees
over the past year as well as information on director attendance.
4.
How the insurer or insurance group identifies, nominates and elects
members to the Board and its committees. The discussion should include,
for example:
a.
Whether a nomination committee is in place to identify and select
individuals for consideration.
b.
Whether term limits are placed on directors.
c.
How the election and re-election processes function.
d.
Whether a Board diversity policy is in place and if so, how it
functions.
5.
The processes in place for the Board to evaluate its performance
and the performance of its committees, as well as any recent
measures taken to improve performance (including any Board or
committee training programs that have been put in place).
D.
The insurer or insurance group shall describe the policies and practices for
directing Senior Management, including a description of the following factors:
1.
Any processes or practices (i.e., suitability standards) to determine
whether officers and key persons in control functions have the appropriate
background, experience and integrity to fulfill their prospective roles,
including:
a.
Identification of the specific positions for which suitability standards
have been developed and a description of the standards employed.
b.
Any changes in an officer’s or key person’s suitability as outlined by
the insurer’s or insurance group’s standards and procedures to
monitor and evaluate such changes.
2.
The insurer’s or insurance group’s code of business conduct and ethics,
the discussion of which considers, for example:
a.
compliance with laws, rules, and regulations; and
b.
proactive reporting of any illegal or unethical behavior.
3.
The insurer’s or insurance group’s processes for performance evaluation,
compensation and corrective action to ensure effective senior
management throughout the organization, including a description of the
general objectives of significant compensation programs and what the
programs are designed to reward. The description shall include sufficient
detail to allow the Commissioner to understand how the organization
ensures that compensation programs do not encourage and/or reward
excessive risk taking. Elements to be discussed may include, for example:
a.
The Board’s role in overseeing management compensation
programs and practices.
b.
The various elements of compensation awarded in the insurer’s or
insurance group’s compensation programs and how the insurer or
insurance group determines and calculates the amount of each
element of compensation paid;
c.
How compensation programs are related to both company and
individual performance over time;
d.
Whether compensation programs include risk adjustments and how
those adjustments are incorporated into the programs for
employees at different levels;
e.
Any clawback provisions built into the programs to recover awards
or payments if the performance measures upon which they are
based are restated or otherwise adjusted;
f.
Any other factors relevant in understanding how the insurer or
insurance group monitors its compensation policies to determine
whether its risk management objectives are met by incentivizing its
employees.
4.
The insurer’s or insurance group’s plans for CEO and Senior Management
succession.
E.
The insurer or insurance group shall describe the processes by which the Board,
its committees and Senior Management ensure an appropriate amount of
oversight to the critical risk areas impacting the insurer’s business activities,
including a discussion of:
1.
How oversight and management responsibilities are delegated between
the Board, its committees and Senior Management;
2.
How the Board is kept informed of the insurer’s strategic plans, the
associated risks, and steps that Senior Management is taking to monitor
and manage those risks;
3.
How reporting responsibilities are organized for each critical risk area.
The description should allow the Commissioner to understand the
frequency at which information on each critical risk area is reported to and
reviewed by Senior Management and the Board. This description may
include, for example, the following critical risk areas of the insurer:
a.
Risk management processes (An ORSA Summary Report filer may
refer to its ORSA Summary Report pursuant to the Risk
Management and Own Risk and Solvency Assessment Model Act);
b.
Actuarial function;
c.
Investment decision-making processes;
d.
Reinsurance decision-making processes;
e.
Business strategy/finance decision-making processes;
f.
Compliance function;
g.
Financial reporting/internal auditing; and
h.
Market conduct decision-making processes.
1.6
Severability Clause
If any provision of this regulation, or the application thereof to any person or
circumstance, is held invalid, such determination shall not affect other provisions
or applications of these regulations which can be given effect without the invalid
provision or application, and to that end the provisions of these regulations are
severable.